miscellaneous - living meta-analysis of clinical studies

table network network 2

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID 19 hospitalized
	COVID 19 hospitalized	COVID 19 all comers	COVID-19 mild to moderate	COVID-19 severe or critically
miscellaneous
Aspirin	RECOVERY ...
camostat mesilate		Gunst JD
Cannabidiol			Crippa ...
pyridostigmine				Fragoso-Saavedra ...
sabizabulin			VERU-111

17 studies excluded by filtering options 0

4960	Ming Zhong, 2020	1	1	3			high risk of bias
4977	COVID-AIV, 0	0	0	0	selection pending
5369	Hopkinson, 2020	0	15	0	selection pending
5418	Aveyard, 0	0	13	0	selection pending
5420	Hernandez, 2020	0	13	0	selection pending
5424	Israel, 0	0	13	0	selection pending
5530	Hess (Emory), 2020	0	13	0	selection pending
5618	Zhang, 2020	0	13	0	selection pending
5620	Mansour, 0	0	1	0	selection pending
5627	van de Veerdonk, 2020	0	13	0	selection pending
5671	Aisa-Alvarez, 2020	2	1	0	excluded		risk of bias not avaialble
5841	Mohamed, 2020	1	1	0			risk of bias not avaialble
5962	de Alencar, 2020	0	0	0	selection pending
6573	Guenezan, 2021	0	1	0	selection pending
6943	Seet (povidone iodine), 2021	0	1	0	selection pending
6973	ACTIV-3 Critical Care, 2022	1	1	0			risk of bias not avaialble
9583	Chow, 2022	0	13	0	selection pending